Latest News
PRESS RELEASE
OCTOBER 27, 2021
Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital
PORTFOLIO NEWS
MARCH 18, 2022
Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035
Published in Press Release
PORTFOLIO NEWS
FEBRUARY 23, 2022
Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer
Published in Press Release
PORTFOLIO NEWS
FEBRUARY 16, 2022
Cardurion Pharmaceuticals Enhances Leadership Team with Appointment of Marcia Moore as Chief Operating Officer
Published in Press Release
PORTFOLIO NEWS
JANUARY 10, 2022
Medtronic to acquire Affera, a cardiac arrhythmia technology firm, for $925 million
Published in Minnesota Star Tribune
PORTFOLIO NEWS
DECEMBER 21, 2021
